The following number of stock options, warrants,
pre-funded warrants, and convertible Preferred Stock were excluded from the calculation of diluted loss per share because their effect
would have been anti-dilutive for the periods presented (share data):
SCHEDULE OF ANTI-DILUTIVE SECURITIES
| | |
Weighted average | |
| | |
For the Three Months Ended June 30, | | |
For the Six Months Ended June 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Warrants | |
| 1,788,729 | | |
| 312,354 | | |
| 1,788,729 | | |
| 306,861 | |
| Outstanding stock options | |
| 119,244 | | |
| 102,659 | | |
| 136,814 | | |
| 102,842 | |
| Pre-funded warrants | |
| 221,005 | | |
| - | | |
| 221,005 | | |
| - | |
| Preferred stock | |
| - | | |
| - | | |
| 455,556 | | |
| - | |
|